ARTICLE | Company News
Aptein, Cambridge Antibody deal
June 7, 1999 7:00 AM UTC
CAT issued 1.1 million common shares valued at $5 million to Aptein shareholders to complete the purchase of Aptein for a total of $11 million (see BioCentury, June 29, 1998). The issue was triggered ...